“Comparison of Adverse Events Between Selective Internal Radiation Therapy Versus Sorafenib in Locally Advanced Hepatocellular Carcinoma in Mongolia: A Subgroup Analysis of SIRveNIB Study” (2017) Central Asian Journal of Medical Sciences, 3(3), pp. 297–305. doi:10.24079/cajms.2017.11.011.